Business Process Outsourcing
PRODUCTS
-
Elevate Your Clinical Research Data Collection
-
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
It’s about time.
Modern eConsent.
Solved.Deliver complex eConsent experiences that participants will love. Drive compliance and retention with truly informed participants, using a system that is easy to configure and manage from site to subject.
-
Strategic product development and CMC regulatory planning start early on at the pre-IND stage and apply to the entire development lifecycle through to post-approval.
-
Our model combines the depth and experience level of our people with effective tools and processes already in place that are designed to ensure your critical eTMF documents and content are secure, organized, readily accessible, and always in complete compliance with all relevant regulations.
WHITE PAPERS AND CASE STUDIES
-
Buffers And Process Liquids For Biopharmaceutical Production: Considerations For Scale-Up And Outsourcing
For small and midsize biopharmaceutical organizations, outsourcing buffer and process liquid preparation, quality testing, and storage could significantly streamline operations and reduce regulatory risk.
-
Earning RMAT Designation - What Developers Need To Know
Explore a high-level overview of the Regenerative Medicine Advanced Therapy designation and how to ensure success and accelerate advanced therapy products toward commercialization.
-
Optimized Stability Storage
A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.
-
CDMO Accelerates Contract Manufacturing With Electronic Batch Records
A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.
-
An Experienced CDMO Can Be A Differentiator In The Rapidly Growing Biologics Market
Discover how an experienced CDMO offering a purpose-built facility with flexible capacity can help biopharmaceutical companies bring their products to market quickly and efficiently.
-
How Community Oncologists View CAR T-Cell Therapy Possibilities And Challenges
Learn how a partner with innovative solutions aimed at overcoming the barriers that limit the real-world impact of CAR T-cell therapy can make these advanced therapies more accessible and affordable.
-
Navigating The Complexities Of CGTs With Regulatory And CMC Expertise
Review the submission process and CMC expertise which helped a biopharmaceutical company targeting a rare-disease tumor type avoid a clinical hold and advance to phase 1 clinical trials.
-
A New Approach To Characterizing Crystalline Structure
Learn how the accuracy (melting temperature and heat of fusion) and utility of Differential Scanning Calorimetry data is greatly diminished for materials that undergo Apparent Melting and much more.
-
Targeting Macular Degeneration With Stem Cell Therapy
A novel stem-cell therapy based upon iPSC-derived RPE cell transplantation was conceptualized as a promising new treatment for AMD and other retinal diseases.
-
IT Changes Implemented To Overcome Future Manufacturing Challenges
Learn how Pfizer and Ferring improved their reporting and batch information management with Rockwell’s technology.
-
Simplify CAPA In 7 Steps
Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
NEWS
-
AI Speeding Discovery Of New Drugs8/6/2024
The human body contains at least 20,000 different proteins, often called the “workhorses of the cell” because of their role in keeping cells healthy.
-
Arcpoint Adds Functionality To Enable Telehealth Practitioners To Order Diagnotic Tests Through Arcpoint System9/18/2024
ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to report that it has implemented an integration that allows telehealth doctors and other practitioners to order diagnostic tests through physical locations connected by ARCpoint’s MyARCpointLabs technology platform.
-
The FDA's Proposed Ruling On Lab Tests Could Have Unintended Consequences2/6/2024
Yale experts are raising concerns about a rule proposed by the U.S. Food and Drug Administration (FDA) to enforce the agency’s regulatory control over laboratory-developed tests, or LDTs. The tests play a critical role in filling gaps in commercial testing, such as diagnostic tests for rare diseases deemed unprofitable by manufacturers.
-
Engineers Bring Efficient Optical Neural Networks Into Focus8/6/2024
EPFL researchers have published a programmable framework that overcomes a key computational bottleneck of optics-based artificial intelligence systems.
-
Cancer Drug Discovery Accelerated As Hundreds Of Overlooked Targets Prioritised1/11/2024
A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.